ArticleFrontiers in oncology2022

Assessment of the Novel, Practical, and Prognosis-Relevant TNM Staging System for Stage I-III Cutaneous Melanoma.

Di Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.